E. Tchesnokov

Infectious Diseases · 2020

A researcher in the Science corpus: 2 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom E. Tchesnokov trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Matthew P. Jacobson
  2. A. Ward

Papers from E. Tchesnokov's perspective

Ordered by how strongly the researchers E. Tchesnokov trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Therapeutic Efficacy of the Small Molecule GS-5734 against Ebola Virus in Rhesus Monkeys (Nature)
  2. A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics (New England Journal of Medicine)
  3. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro (Cell Research)
  4. Screening of an FDA-Approved Compound Library Identifies Four Small-Molecule Inhibitors of Middle East Respiratory Syndrome Coronavirus Replication in Cell Culture (Antimicrobial Agents and Chemotherapy)
  5. Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection (Proceedings of the National Academy of Sciences of the United States of America)
  6. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding (The Lancet)
  7. A hierarchical approach to all‐atom protein loop prediction
  8. Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase (Proceedings of the Japan Academy. Series B, Physical and biological sciences)
  9. The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus (Journal of Biological Chemistry)
  10. Structure of the SARS-CoV nsp12 polymerase bound to nsp7 and nsp8 co-factors (Nature Communications)

Their papers